WallStreetZenWallStreetZen

NASDAQ: EKSO
Ekso Bionics Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for EKSO

Based on 2 analysts offering 12 month price targets for Ekso Bionics Holdings Inc.
Min Forecast
$2.50+110.08%
Avg Forecast
$6.25+425.21%
Max Forecast
$10.00+740.34%

Should I buy or sell EKSO stock?

Based on 2 analysts offering ratings for Ekso Bionics Holdings Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EKSO stock forecasts and price targets.

EKSO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-24
lockedlocked$00.00+00.00%2024-04-30

1 of 1

Forecast return on equity

Is EKSO forecast to generate an efficient return?
Company
N/A
Industry
8.25%
Market
80.54%

Forecast return on assets

Is EKSO forecast to generate an efficient return on assets?
Company
N/A
Industry
4.13%

EKSO earnings per share forecast

What is EKSO's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.43
Avg 2 year Forecast
-$0.19

EKSO revenue forecast

What is EKSO's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$21.6M+20.3%
Avg 2 year Forecast
$27.8M+55.25%
Avg 3 year Forecast
$35.6M+98.57%
EKSO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EKSO revenue growth forecast

How is EKSO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
25.69%
Industry
8.65%
Market
10.57%
EKSO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EKSO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EKSO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
EKSO$1.19$6.25+425.21%Strong Buy
OMIC$8.74$10.75+23.00%Hold
MHUA$0.94N/AN/A
NEPH$2.29$5.00+118.34%Buy
FEMY$1.14$11.67+923.42%Strong Buy

Ekso Bionics Holdings Stock Forecast FAQ

Is Ekso Bionics Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EKSO) stock is to Strong Buy EKSO stock.

Out of 2 analysts, 1 (50%) are recommending EKSO as a Strong Buy, 1 (50%) are recommending EKSO as a Buy, 0 (0%) are recommending EKSO as a Hold, 0 (0%) are recommending EKSO as a Sell, and 0 (0%) are recommending EKSO as a Strong Sell.

If you're new to stock investing, here's how to buy Ekso Bionics Holdings stock.

What is EKSO's earnings growth forecast for 2024-2025?

(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 18.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.02%.

Ekso Bionics Holdings's earnings in 2024 is -$14,238,000.On average, 1 Wall Street analyst forecast EKSO's earnings for 2024 to be -$7,815,003, with the lowest EKSO earnings forecast at -$7,815,003, and the highest EKSO earnings forecast at -$7,815,003.

In 2025, EKSO is forecast to generate -$3,453,141 in earnings, with the lowest earnings forecast at -$3,453,141 and the highest earnings forecast at -$3,453,141.

What is EKSO's revenue growth forecast for 2024-2026?

(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual revenue growth rate of 25.69% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.57%.

Ekso Bionics Holdings's revenue in 2024 is $17,913,000.On average, 1 Wall Street analysts forecast EKSO's revenue for 2024 to be $391,658,880, with the lowest EKSO revenue forecast at $391,658,880, and the highest EKSO revenue forecast at $391,658,880. On average, 1 Wall Street analysts forecast EKSO's revenue for 2025 to be $505,430,787, with the lowest EKSO revenue forecast at $505,430,787, and the highest EKSO revenue forecast at $505,430,787.

In 2026, EKSO is forecast to generate $646,464,333 in revenue, with the lowest revenue forecast at $646,464,333 and the highest revenue forecast at $646,464,333.

What is EKSO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: EKSO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 4.13%.

What is EKSO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EKSO price target, the average EKSO price target is $6.25, with the highest EKSO stock price forecast at $10.00 and the lowest EKSO stock price forecast at $2.50.

On average, Wall Street analysts predict that Ekso Bionics Holdings's share price could reach $6.25 by Jun 24, 2025. The average Ekso Bionics Holdings stock price prediction forecasts a potential upside of 425.21% from the current EKSO share price of $1.19.

What is EKSO's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: EKSO) Ekso Bionics Holdings's current Earnings Per Share (EPS) is -$0.97. On average, analysts forecast that EKSO's EPS will be -$0.43 for 2024, with the lowest EPS forecast at -$0.43, and the highest EPS forecast at -$0.43. In 2025, EKSO's EPS is forecast to hit -$0.19 (min: -$0.19, max: -$0.19).

What is EKSO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: EKSO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.